Loading...
In silico design of two novel fusion proteins, p28-IL-24 and p28-M4, targeted to breast cancer cells
BACKGROUND AND PURPOSE: An anticancer peptide P28, has shown to be cytolethal on various cancer cells including breast cancer. Moreover, p28 can be also used as a targeting moiety in the structure of fusion proteins. IL-24 (or its truncated form, M4) is a cytokine with anticancer activity against a...
Na minha lista:
| Udgivet i: | Res Pharm Sci |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wolters Kluwer - Medknow
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7306244/ https://ncbi.nlm.nih.gov/pubmed/32582360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1735-5362.283820 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|